inōtiv Corporate Presentation June 2023
Product Offerings At a Glance
Our focus is on driving innovation and discovery for the world's leading biopharmaceutical and
medical research organizations
Discovery and Safety Assessment
We support the needs of researchers and
clinicians for small molecule drug
candidates, biotherapeutics, and medical
devices, from Discovery to Preclinical
Development and through phased clinical
assessments
Segment Revenues
(YTD June 2023 Revenues)
Key service offerings include
pharmacology, toxicology, DMPK,
histopathology and associated
bioanalytical support, plus centers of
expertise in surgical models and medical
device testing, and experienced
consulting teams
6 |
DMPK - Drug metabolism and pharmacokinetics.
$134.9M
(31%)
$296.8M
(69%)
DSA
■RMS
Research Models and
Services
•
.
Key offerings include large and small
research models, Teklad diets, bedding,
genetic modification services and other
support services
Supports CRO, academic, pharma, and
government clients through delivery of
genetically consistent, high-health
status research models
Relationships with critical NHP
suppliers across an international
logistics network
High customer retention rate
Incredibly durable client relationships
(18 of top 20 clients have been repeat
clients for 10+ years)
CORPORATE PRESENTATION
inōtiv
analyze, answer. advance..View entire presentation